2012 | Predictive value of HBsAg quantification for determining the clinical course of genotype C HBeAg-negative carriers. | LIVER INTERNATIONAL |
2021 | Predictors of Complete Response in Patients with Hepatocellular Carcinoma Treated with Trans-Arterial Radioembolization
| CURRENT ONCOLOGY |
2019 | Predictors of Discordance in the Assessment of Skeletal Muscle Mass between Computed Tomography and Bioimpedance Analysis
| JOURNAL OF CLINICAL MEDICINE |
2018 | Predictors of failure to detect early hepatocellular carcinoma in patients with chronic hepatitis B who received regular surveillance | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
2013 | Predictors of Refractory Ascites Development in Patients with Hepatitis B Virus-Related Cirrhosis Hospitalized to Control Ascitic Decompensation
| YONSEI MEDICAL JOURNAL |
2022 | Predictors of Sarcopenia in an Obese Asian Population | NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL |
2008 | Prevalence and genotype distribution of hepatitis C virus among apparently healthy individuals in Mongolia: a population-based nationwide study. | LIVER INTERNATIONAL |
2017 | Prevalence and Predictors of Significant Fibrosis Among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver Disease | DIGESTIVE DISEASES AND SCIENCES |
2022 | Prevalence and Risk Factors of Cardiovascular Disease in Patients with Chronic Hepatitis B | DIGESTIVE DISEASES AND SCIENCES |
2020 | Prevention and management of viral hepatitis in inflammatory bowel disease: a clinical practice guideline by the Korean Association for the Study of Intestinal Diseases
| INTESTINAL RESEARCH |
2020 | Prognosis of Early-Stage Hepatocellular Carcinoma: Comparison between Trans-Arterial Chemoembolization and Radiofrequency Ablation
| CANCERS |
2014 | Prognosis of hepatocellular carcinoma patients with extrahepatic metastasis and the controllability of intrahepatic lesions | CLINICAL & EXPERIMENTAL METASTASIS |
2019 | Prognosis of Untreated Minimally Active Chronic Hepatitis B Patients in Comparison With Virological Responders by Antivirals | CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY |
2011 | Prognostic factors and 10-year survival in patients with hepatocellular carcinoma after curative hepatectomy | JOURNAL OF GASTROINTESTINAL SURGERY |
2017 | Prognostic factors of sorafenib therapy in hepatocellular carcinoma patients with failure of transarterial chemoembolization | HEPATOLOGY INTERNATIONAL |
2014 | Prognostic Indicators for Acute Liver Failure Development and Mortality in Patients with Hepatitis A: Consecutive Case Analysis
| YONSEI MEDICAL JOURNAL |
2015 | Prognostic role of magnetic resonance imaging vs. computed tomography for hepatocellular carcinoma undergoing chemoembolization | LIVER INTERNATIONAL |
2016 | Prognostic Significance of ¹?F-FDG Uptake in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization or Concurrent Chemoradiotherapy: A Multicenter Retrospective Cohort Study
| JOURNAL OF NUCLEAR MEDICINE |
2011 | Prognostic value of 18F-FDG PET for hepatocellular carcinoma patients treated with sorafenib | LIVER INTERNATIONAL |
2021 | Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma
| YONSEI MEDICAL JOURNAL |
2017 | Prognostic Value of FDG Uptake of Portal Vein Tumor Thrombosis in Patients With Locally Advanced Hepatocellular Carcinoma | CLINICAL NUCLEAR MEDICINE |
2013 | Prognostic Value of Model for End-Stage Liver Disease Scores in Patients with Fulminant Hepatic Failure | TRANSPLANTATION PROCEEDINGS |
2011 | Prognostic value of the 7th edition of the AJCC staging system as a clinical staging system in patients with hepatocellular carcinoma. | EUROPEAN JOURNAL OF CANCER |
2015 | Prognostic value of the combined use of transient elastography and fibrotest in patients with chronic hepatitis B | LIVER INTERNATIONAL |
2013 | Prognostic value of α-fetoprotein and des-γ-carboxy prothrombin responses in patients with hepatocellular carcinoma treated with transarterial chemoembolization
| BMC CANCER |
2019 | Progression of Untreated Minimally Active Chronic HBV Infection Compared to Inactive Infection | CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
2020 | Proposal of a New Risk Score for Patients Treated with Transarterial Chemoembolization due to Recurrent Hepatocellular Carcinoma after Curative Resection: A Multicenter Study
| GUT AND LIVER |
2012 | Prospective validation of ELF test in comparison with Fibroscan and FibroTest to predict liver fibrosis in Asian subjects with chronic hepatitis B
| PLOS ONE |
2012 | Prospective validation of FibroTest in comparison with liver stiffness for predicting liver fibrosis in Asian subjects with chronic hepatitis B
| PLOS ONE |
2010 | Prospective validation of P2/MS noninvasive index using complete blood counts for detecting oesophageal varices in B-viral cirrhosis | LIVER INTERNATIONAL |
2013 | Proteomic and lipidomic signatures of lipid metabolism in NASH-associated hepatocellular carcinoma
| CANCER RESEARCH |
2011 | Quantitative hepatitis B surface antigen and hepatitis B e antigen titers in prediction of treatment response to entecavir. | HEPATOLOGY |
2013 | Quasispecies and Pre-Existing Drug-Resistant Mutations of Hepatitis B Virus in Patients with Chronic Hepatitis B
| GUT AND LIVER |
2016 | Radioembolization Is a Safe and Effective Treatment for Hepatocellular Carcinoma with Portal Vein Thrombosis: A Propensity Score Analysis
| PLOS ONE |
2015 | Radioembolization With Yttrium-90 Resin Microspheres in Hepatocellular Carcinoma: A Multicenter Prospective Study | AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS |
2012 | Radiological response predicts survival following transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
2019 | Radiomics on Gadoxetic Acid-Enhanced Magnetic Resonance Imaging for Prediction of Postoperative Early and Late Recurrence of Single Hepatocellular Carcinoma
| CLINICAL CANCER RESEARCH |
2018 | Randomized, prospective, comparative study on the effects and safety of sorafenib vs. hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
2016 | Real-Life Experience of Sorafenib Treatment for Hepatocellular Carcinoma in Korea: From GIDEON Data
| CANCER RESEARCH AND TREATMENT |
2016 | Red cell volume distribution width-to-platelet ratio in assessment of liver fibrosis in patients with chronic hepatitis B | LIVER INTERNATIONAL |
2019 | Refractoriness to transarterial chemoembolization in patients with recurrent hepatocellular carcinoma after curative resection
| PLOS ONE |
2015 | Relationship between Cerebral Microbleeds and Liver Stiffness Determined by Transient Elastography
| PLOS ONE |
2018 | Reply to "Radiologic Evaluation of Intrahepatic Cholangiocarcinoma Perineural Invasion" | AMERICAN JOURNAL OF ROENTGENOLOGY |
2018 | Reproducibility of European Association for the Study of the Liver criteria and modified Response Evaluation Criteria in Solid Tumors in patients treated with sorafenib | LIVER INTERNATIONAL |
2009 | Rescue monotherapy in lamivudine-resistant hepatitis B e antigen-positive chronic hepatitis B: adefovir versus entecavir | ANTIVIRAL THERAPY |
2019 | Retrospective analysis of stereotactic body radiation therapy efficacy over radiofrequency ablation for hepatocellular carcinoma | RADIOTHERAPY AND ONCOLOGY |
2020 | Retrospective comparison of EASL 2018 and LI-RADS 2018 for the noninvasive diagnosis of hepatocellular carcinoma using magnetic resonance imaging | HEPATOLOGY INTERNATIONAL |
2021 | Revised Korean Antiviral Guideline Reduces the Hepatitis B-related Hepatocellular Carcinoma Risk in Cirrhotic Patients
| JOURNAL OF KOREAN MEDICAL SCIENCE |
2021 | Risk and Risk Score Performance of Hepatocellular Carcinoma Development in Patients With Hepatitis B Surface Antigen Seroclearance
| CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY |
2014 | Risk assessment of clinical outcomes in Asian patients with chronic hepatitis B using enhanced liver fibrosis test. | HEPATOLOGY |
2012 | Risk assessment of development of hepatic decompensation in histologically proven hepatitis B viral cirrhosis using liver stiffness measurement. | DIGESTION |
2011 | Risk assessment of esophageal variceal bleeding in B-viral liver cirrhosis by a liver stiffness measurement-based model. | AMERICAN JOURNAL OF GASTROENTEROLOGY |
2011 | Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan). | HEPATOLOGY |
2021 | Risk assessment of hepatocellular carcinoma and liver-related events using ultrasonography and transient elastography in patients with chronic hepatitis B | JOURNAL OF VIRAL HEPATITIS |
2019 | Risk assessment of hepatocellular carcinoma development for indeterminate hepatic nodules in patients with chronic hepatitis B
| CLINICAL AND MOLECULAR HEPATOLOGY |
2014 | Risk Assessment of Liver-related Events Using Transient Elastography in Patients With Chronic Hepatitis B Receiving Entecavir | JOURNAL OF CLINICAL GASTROENTEROLOGY |
2011 | Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score. | LANCET ONCOLOGY |
2016 | Risk prediction for patients with hepatocellular carcinoma undergoing chemoembolization: development of a prediction model | LIVER INTERNATIONAL |
2021 | Risk stratification using sarcopenia status among subjects with metabolic dysfunction-associated fatty liver disease
| JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE |
2009 | Role of serum prothrombin induced by vitamin K absence or antagonist-II in the early detection of hepatocellular carcinoma in patients with chronic hepatitis B virus infection | SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY |